Welcome to Imarkplace!

imarkplace

Category: politics

QIAGEN NV : Gets a Buy rating from Jefferies

Market Screener With Dpa-Afx Analyser

12299f7807378d0d7a6e.kzoWVAdAQ0YBRI-1Bjoq6TsrhG4cqCK1lMP2GwPcy1Y.11BGZnV1BzROEb-DaUpLjVN5vDRk_lDt_KKjIzCQqSziX1gnNRB6ITAnwg

Create an account

Continue with Google

Continue with Apple

Continue with LinkedIn

or by email

Continue with an email

Create an account with Google

Create an account with Apple

Create an account with LinkedIn

or by email

Create an account

Enter your password

ContinueForgot your password ?

Top Capitalization United States North America

Middle East Sector Research Company Calendar Equity Analysis

Most popular SPACEX (SPACE EXPLORATION TECHNOLOGIES)

NVIDIA CORPORATION MICROSOFT CORPORATION MICRON TECHNOLOGY, INC. META PLATFORMS, INC. WELLS FARGO & COMPANY

Index Analysis Indices News

EURO STOXX 50

Currency / Forex

Currency Cross Rate Currency Converter Forex Analysis Currencies News

Commodities

Precious metals Agriculture Industrial Metals Livestock and Cattle

CRUDE OIL (WTI) CRUDE OIL (BRENT)

Cryptocurrencies

BINANCE COIN

Interest Rates

Yield Curve Developed Markets Emerging Markets

Macroeconomics

Geopolitics

International Trade Military conflicts

Sustainable development Legal, Regulation and Crime

Financial Results Analyst Recommendations Transcripts Press releases Insider transaction Controversies Innovations and expansions

Negative surprises Positive surprises New Contracts

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Most Read News

Business Insiders

All Articles

Equity Analysis

Commodities

Cryptocurrencies

Economic Calendar

Company Calendar

Dividend calendar Stock Picks

All our investments

United States

Asia, Pacific

USA Portfolio

European Portfolio

Asian Portfolio

Virtual Portfolios

My Watchlists

My previous session My most visited Most popular

Investment Style

Growth stocks Yield stocks Multibaggers

Momentum stocks Low volatility

Investment Themes

Space Exploration Warren Buffett Millennials

Market Timing

Pre/Post-Market Movers

Technical Alerts

Insider transactions

Dynamic Chart

Currency Converter

Short-Term Gainers & Losers Long-term Gainers & Losers Unusual Volumes New Historical Highs New Historical Lows

Pre/Post-Market Movers

Top Fundamentals

Fundamental Composite Sales Growth Earnings Growth Profitability

Visibility Rankings

Rankings Valuation

Valuation Composite

Enterprise Value

Price to Book (PBR) Free Cash Flow (FCF)

Top Consensus

Consensus Composite Analyst Opinion Target Price Opinion Divergences Estimates Revisions Analyst Coverage

Technical Analysis Rankings

Daily Breakouts Weekly Breakouts

Top ranking ESG

Environment

Islamic Finance Paris Agreement

Top Capitalization United States North America

Middle East Sector Research Company Calendar Equity Analysis Most popular SPACEX (SPACE EXPLORATION TECHNOLOGIES)

NVIDIA CORPORATION MICROSOFT CORPORATION MICRON TECHNOLOGY, INC. META PLATFORMS, INC. WELLS FARGO & COMPANY

Index Analysis Indices News

EURO STOXX 50

Currency / Forex

Currency Cross Rate Currency Converter Forex Analysis Currencies News

Commodities

Precious metals Agriculture Industrial Metals Livestock and Cattle

CRUDE OIL (WTI) CRUDE OIL (BRENT)

Cryptocurrencies

BINANCE COIN

Interest Rates

Yield Curve Developed Markets Emerging Markets

Macroeconomics

Geopolitics

International Trade Military conflicts

Sustainable development Legal, Regulation and Crime

Financial Results Analyst Recommendations Transcripts Press releases Insider transaction Controversies Innovations and expansions

Negative surprises Positive surprises New Contracts

Currency / Forex Commodities Cryptocurrencies

Interest Rates

Most Read News

Business Insiders

All Articles

Equity Analysis

Commodities

Cryptocurrencies

Economic Calendar Company Calendar Dividend calendar

Stock Picks

All our investments United States

Asia, Pacific

USA Portfolio European Portfolio Asian Portfolio Virtual Portfolios

My Watchlists

My previous session My most visited Most popular

Investment Style

Growth stocks Yield stocks Multibaggers

Momentum stocks Low volatility

Investment Themes

Space Exploration Warren Buffett Millennials

Market Timing

Pre/Post-Market Movers Technical Alerts

Insider transactions

Dynamic Chart Currency Converter

Short-Term Gainers & Losers Long-term Gainers & Losers Unusual Volumes New Historical Highs New Historical Lows Pre/Post-Market Movers

Top Fundamentals

Fundamental Composite Sales Growth Earnings Growth Profitability

Visibility Rankings

Rankings Valuation

Valuation Composite

Enterprise Value

Price to Book (PBR) Free Cash Flow (FCF)

Top Consensus

Consensus Composite Analyst Opinion Target Price Opinion Divergences Estimates Revisions Analyst Coverage

Technical Analysis Rankings

Daily Breakouts Weekly Breakouts

Top ranking ESG

Environment

Islamic Finance Paris Agreement Switch edition

QIAGEN N.V.

Add to a list

Qiagen N.V.

NL0015002SN0

Biotechnology & Medical Research

Market Closed -

Other stock markets

04:00:02 2026-06-12 pm EDT

After hours

07:55:18 pm

Wanted: Billions in Venture Capital to Fuel Growth

AlphaValue/Baader Europe Cuts Qiagen Price Target, Estimates Post FY26 Guidance Change

Technical Analysis

Static Chart

Total Return chart

Sector Chart

Comparison Chart

Relative Strength Chart

Analyst Reco.

Transcripts

Press Releases

Official Publications

Other languages

MarketScreener Editorial Features

MarketScreener Strategies

Share ownership

Insider transactions

Connections

Analysts' Forecasts

Income Statement

Balance Sheet

Financial Ratios

Business Segments

Valuation ratios

Analysts' Opinion

Estimates Revisions

Sector performance

Sector valuations

Sector dividends

Financial comparisons

Sector ratings

Sector consensus

Sector revisions

Analyst Reco.

Transcripts

Press Releases

Official Publications

Other languages

MarketScreener Editorial Features

MarketScreener Strategies

QIAGEN NV : Gets a Buy rating from Jefferies

Published on 11/20/2025 at 01:59 am EST

MarketScreener with dpa-AFX Analyser

QIAGEN N.V.

Jefferies is positive on the stock with a Buy rating.

© MarketScreener with dpa-AFX Analyser -

Latest news about Qiagen N.V.

Wanted: Billions in Venture Capital to Fuel Growth

AlphaValue/Baader Europe Cuts Qiagen Price Target, Estimates Post FY26 Guidance Change

Qiagen N.V. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 11:40 AM

QIAGEN NV :Deutsche Bank keeps its Buy rating

Alerts on Qiagen N.V. withdrawn

Qiagen supports infectious disease research and surveillance efforts for Bundibugyo ebolavirus outbreak

Qiagen Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak

Alerts on Qiagen N.V. withdrawn

QIAGEN NV :Buy rating from Deutsche Bank

QIAGEN N.V. Launches QIA Agent, AI-Powered Digital Assistant

Qiagen's Digital Insights Business to Integrate Nvidia's BioNeMo Platform

Qiagen N.V. Integrates Nvidia Accelerated Computing and Bionemo Platform with Qiagen Digital Insights? Curated Biomedical Knowledge Bases

Qiagen N.V. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:00 PM

Qiagen N.V. Proposes Annual Cash Dividend, Payable on July 14, 2026

Qiagen N.V. Announces Metin Colpan Decides Not to Stand for Re-Election of Supervisory Board

Chart Qiagen N.V.

QGEN: Dynamic Chart

Company Profile

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Biotechnology & Medical Research

Ex-dividend date - 0.35 USD

More about the company

Income Statement and Estimates

More financial data

Analysis / Opinion

Qiagen: Turbulence, not trajectory change

May 11, 2026 at 05:45 pm EDT

More analyses

This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.

This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.

The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

More Ratings

Analysts' Consensus

Mean consensus

Number of Analysts

Last Close Price

Average target price

Spread / Average Target

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

My Watchlist

More Rankings

More Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market Stock Market News QIAGEN NV :Gets a Buy rating from Jefferies

Best financial

More than 20 years at your side

+ 1,300,000

Quick & easy cancellation

Our Experts are here for you

OUR EXPERTS ARE HERE FOR YOU Monday - Friday 9am-12pm / 2pm-6pm GMT + 1

Legal information

Cookie settings

MarketScreener Blog

Copyright © 2026 Surperformance SAS. All rights reserved.

Stock quotes are provided by Factset, Morningstar and S&P Capital IQ

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!

SEIZE THE OFFER!

Select your edition All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

MIDDLE EAST

Saudi Arabia United Arab Emirates

Deutschland

United Kingdom